Browsing by Author "Katlama, Christine"
Now showing items 1-11 of 11
-
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
Clotet, Bonaventura et al. | Date Issued: 2007 -
Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials
Katlama, Christine et al. | Date Issued: 2010 -
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Katlama, Christine et al. | Date Issued: 2009 -
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1
Katlama, Christine et al. | Date Issued: 2007 -
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study
Gatell, Jose M et al. | Date Issued: 2010 -
Raltegravir with optimized background therapy for resistant HIV-1 infection
Steigbigel, Roy T. et al. | Date Issued: 2008 -
Safety and efficacy of Darunavir (TMC114) with low-dose Ritonavir in treatment-experienced patients: 24-week results of POWER 3
Molina, Jean-Michel et al. | Date Issued: 2007 -
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
Grinsztejn, Beatriz et al. | Date Issued: 2007 -
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection
Cooper, David A. et al. | Date Issued: 2008